Compounded non-FDA–approved menopausal hormone therapy prescriptions have increased: results of a pharmacy survey

Por Pinkerton, JoAnn V., Constantine, Ginger D.
Publicado no Menopause (2016)

Endometrial safety of ospemifene: results of the phase 2/3 clinical development program

Por Constantine, Ginger D., Goldstein, Steven R., Archer, David F.
Publicado no Menopause (2015)

Prescribing of FDA-approved and compounded hormone therapy differs by specialty

Por Constantine, Ginger D., Archer, David F., Graham, Shelli, Bernick, Brian A., Mirkin, Sebastian
Publicado no Menopause (2016)

Effects of ospemifene on the female reproductive and urinary tracts: translation from preclinical models into clinical evidence

Por Archer, David F., Carr, Bruce R., Pinkerton, JoAnn V., Taylor, Hugh S., Constantine, Ginger D.
Publicado no Menopause (2015)

Behaviours and attitudes influencing treatment decisions for menopausal symptoms in five European countries

Por Constantine, Ginger D, Graham, Shelli, Clerinx, Cathy, Bernick, Brian A, Krassan, Mitchell, Mirkin, Sebastian, Currie, Heather
Publicado no Post Reprod Health (2016)

Consistency of Effect with a Low-Dose, Estradiol Vaginal Capsule (TX-004HR): Evaluating Improvement in Vaginal Physiology and Moderate-to-Severe Dyspareunia in Subgroups of Postmen...

Por Constantine, Ginger D., Bouchard, Celine, Pickar, James H., Archer, David F., Graham, Shelli, Bernick, Brian, Mirkin, Sebastian
Publicado no J Womens Health (Larchmt) (2017)

Visual improvements in vaginal mucosa correlate with symptoms of VVA: data from a double-blind, placebo-controlled trial

Por Simon, James A., Archer, David F., Kagan, Risa, Bernick, Brian, Graham, Shelli, Constantine, Ginger D., Mirkin, Sebastian
Publicado no Menopause (2017)

Patient acceptability and satisfaction with a low-dose solubilized vaginal estradiol softgel capsule, TX-004HR

Por Kingsberg, Sheryl A., Kroll, Robin, Goldstein, Irwin, Kushner, Harvey, Bernick, Brian, Graham, Shelli, Mirkin, Sebastian, Constantine, Ginger D.
Publicado no Menopause (2017)

TX-004HR vaginal estradiol has negligible to very low systemic absorption of estradiol

Por Archer, David F., Constantine, Ginger D., Simon, James A., Kushner, Harvey, Mayer, Philip, Bernick, Brian, Graham, Shelli, Mirkin, Sebastian
Publicado no Menopause (2017)

The REJOICE trial: a phase 3 randomized, controlled trial evaluating the safety and efficacy of a novel vaginal estradiol soft-gel capsule for symptomatic vulvar and vaginal atroph...

Por Constantine, Ginger D., Simon, James A., Pickar, James H., Archer, David F., Kushner, Harvey, Bernick, Brian, Gasper, Gina, Graham, Shelli, Mirkin, Sebastian
Publicado no Menopause (2017)

Safety of bazedoxifene in a randomized, double-blind, placebo- and active-controlled phase 3 study of postmenopausal women with osteoporosis

Por Christiansen, Claus, Chesnut, Charles H, Adachi, Jonathan D, Brown, Jacques P, Fernandes, César E, Kung, Annie WC, Palacios, Santiago, Levine, Amy B, Chines, Arkadi A, Constantine, Ginger D
Publicado em 2010